Symbols / CODX $1.39 -2.11% Co-Diagnostics, Inc.

Healthcare • Medical Devices • United States • NCM
CODX Chart
About

Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is based in Salt Lake City, Utah.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Medical Devices Market Cap 5.01M
Enterprise Value -5.53M Income -46.90M Sales 622.49K
Book/sh 9.85 Cash/sh 3.30 Dividend Yield —
Payout 0.00% Employees — IPO —
P/E — Forward P/E -0.12 PEG —
P/S 8.04 P/B 0.14 P/C —
EV/EBITDA 0.18 EV/Sales -8.89 Quick Ratio 3.42
Current Ratio 3.87 Debt/Eq 5.99 LT Debt/Eq —
EPS (ttm) -35.25 EPS next Y -12.00 EPS Growth —
Revenue Growth 76.70% Earnings 2026-05-07 ROA -44.28%
ROE -125.89% ROIC — Gross Margin 64.28%
Oper. Margin -29.02% Profit Margin 0.00% Shs Outstand 3.60M
Shs Float 3.44M Short Float 2.86% Short Ratio 0.23
Short Interest — 52W High 46.50 52W Low 1.38
Beta 1.43 Avg Volume 1.22M Volume 78.67K
Target Price — Recom None Prev Close $1.42
Price $1.39 Change -2.11%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$1.39
Latest analyst target
3. DCF / Fair value
$-98.36
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$1.39
Low
—
High
—
Mean
—

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2025-11-26 init Maxim Group — → Buy $2
2025-11-24 reit HC Wainwright & Co. Neutral → Neutral —
2025-10-28 main D. Boral Capital Buy → Buy $3
2025-10-16 main D. Boral Capital Buy → Buy $3
2025-09-19 main D. Boral Capital Buy → Buy $3
2025-09-17 main D. Boral Capital Buy → Buy $10
2025-08-15 main D. Boral Capital Buy → Buy $10
2025-04-28 init D. Boral Capital — → Buy $10
2025-03-28 main HC Wainwright & Co. Neutral → Neutral $1
2024-11-11 reit HC Wainwright & Co. Neutral → Neutral $2
2024-08-12 main HC Wainwright & Co. Neutral → Neutral $2
2024-06-17 reit HC Wainwright & Co. Neutral → Neutral $2
2024-05-13 main HC Wainwright & Co. Neutral → Neutral $2
2024-03-15 main HC Wainwright & Co. Neutral → Neutral $3
2023-12-29 reit HC Wainwright & Co. Neutral → Neutral $3
2023-11-13 main HC Wainwright & Co. Neutral → Neutral $3
2023-08-14 main HC Wainwright & Co. Neutral → Neutral $2
2023-05-15 reit HC Wainwright & Co. Neutral → Neutral $3
2023-03-20 down HC Wainwright & Co. Buy → Neutral $3
2023-02-23 reit HC Wainwright & Co. — → Buy $6
News
RSS: Latest CODX news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2025-11-21 SERBIN RICHARD S Director — 57,499 — —
2025-11-21 SERBIN RICHARD S Director — 228,333 — —
2025-11-21 EGAN DWIGHT H. Chief Executive Officer — 163,333 — —
2025-11-21 EGAN DWIGHT H. Chief Executive Officer — 575,833 — —
2025-11-21 NELSON JAMES B Director — 57,499 — —
2025-11-21 NELSON JAMES B Director — 228,333 — —
2025-11-21 MURPHY EDWARD L. Director — 57,499 — —
2025-11-21 MURPHY EDWARD L. Director — 228,333 — —
2025-11-21 DURENARD EUGENE A Director — 57,499 — —
2025-11-21 DURENARD EUGENE A Director — 228,333 — —
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.62
-84.10%
3.92
-42.53%
6.81
-80.09%
34.22
Operating Revenue
0.62
-84.10%
3.92
-42.53%
6.81
-80.09%
34.22
Cost Of Revenue
0.22
-77.74%
1.00
-76.13%
4.18
-23.65%
5.48
Reconciled Cost Of Revenue
0.22
-77.74%
1.00
-76.13%
4.18
-23.65%
5.48
Gross Profit
0.40
-86.28%
2.92
+11.00%
2.63
-90.86%
28.74
Operating Expense
31.68
-26.31%
43.00
-5.15%
45.33
+12.41%
40.33
Research And Development
19.14
-8.78%
20.98
-8.64%
22.96
+31.68%
17.44
Selling General And Administration
11.44
-44.58%
20.64
-2.36%
21.14
-2.16%
21.61
Selling And Marketing Expense
2.38
-46.89%
4.48
-34.65%
6.86
-6.59%
7.34
General And Administrative Expense
9.06
-43.94%
16.16
+13.15%
14.28
+0.12%
14.26
Other Gand A
9.06
-43.94%
16.16
+13.15%
14.28
+0.12%
14.26
Total Expenses
31.91
-27.48%
44.00
-11.15%
49.52
+8.10%
45.81
Operating Income
-31.28
+21.95%
-40.08
+6.15%
-42.71
-268.43%
-11.59
Total Operating Income As Reported
-50.17
-25.16%
-40.08
+6.15%
-42.71
-58.29%
-26.98
EBITDA
-30.18
+22.03%
-38.70
+6.68%
-41.48
-302.34%
-10.31
Normalized EBITDA
-12.70
+68.48%
-40.30
+10.07%
-44.81
-1571.00%
-2.68
Reconciled Depreciation
1.11
-19.64%
1.38
+11.93%
1.23
-4.07%
1.28
EBIT
-31.28
+21.95%
-40.08
+6.15%
-42.71
-268.43%
-11.59
Total Unusual Items
-17.48
-1196.37%
1.59
-52.18%
3.33
+143.70%
-7.63
Total Unusual Items Excluding Goodwill
-17.48
-1196.37%
1.59
-52.18%
3.33
+143.70%
-7.63
Special Income Charges
-18.16
-2610.98%
0.72
-33.65%
1.09
+114.29%
-7.63
Impairment Of Capital Assets
18.88
0.00
0.00
-100.00%
15.39
Restructuring And Mergern Acquisition
-0.81
-12.73%
-0.71
+34.57%
-1.09
+86.17%
-7.90
Net Income
-46.90
-24.59%
-37.64
-6.53%
-35.33
-148.15%
-14.24
Pretax Income
-48.51
-29.08%
-37.58
+1.39%
-38.11
-102.21%
-18.85
Net Non Operating Interest Income Expense
0.29
-73.17%
1.09
-6.03%
1.16
+65.03%
0.70
Net Interest Income
0.29
-73.17%
1.09
-6.03%
1.16
+65.03%
0.70
Interest Income Non Operating
0.29
-73.17%
1.09
-6.03%
1.16
+65.03%
0.70
Interest Income
0.29
-73.17%
1.09
-6.03%
1.16
+65.03%
0.70
Other Income Expense
-17.52
-1344.56%
1.41
-59.00%
3.43
+143.14%
-7.96
Gain On Sale Of Security
0.68
-21.52%
0.87
-61.18%
2.24
—
Tax Provision
-1.62
-2916.86%
0.06
+102.07%
-2.78
+39.73%
-4.61
Tax Rate For Calcs
0.00
-84.14%
0.00
+187.67%
0.00
-70.20%
0.00
Tax Effect Of Unusual Items
-0.58
-273.91%
0.33
+37.57%
0.24
+113.02%
-1.87
Net Income Including Noncontrolling Interests
-46.90
-24.59%
-37.64
-6.53%
-35.33
-148.15%
-14.24
Net Income From Continuing Operation Net Minority Interest
-46.90
-24.59%
-37.64
-6.53%
-35.33
-148.15%
-14.24
Net Income From Continuing And Discontinued Operation
-46.90
-24.59%
-37.64
-6.53%
-35.33
-148.15%
-14.24
Net Income Continuous Operations
-46.90
-24.59%
-37.64
-6.53%
-35.33
-148.15%
-14.24
Normalized Income
-30.00
+22.87%
-38.90
-1.24%
-38.42
-353.10%
-8.48
Net Income Common Stockholders
-46.90
-24.59%
-37.64
-6.53%
-35.33
-148.15%
-14.24
Diluted EPS
-35.25
+5.29%
-37.22
-3.39%
-36.00
-166.67%
-13.50
Basic EPS
-35.25
+5.29%
-37.22
-3.39%
-36.00
-166.67%
-13.50
Basic Average Shares
1.33
+31.55%
1.01
+3.37%
0.98
-6.77%
1.05
Diluted Average Shares
1.33
+31.55%
1.01
+3.37%
0.98
-6.77%
1.05
Diluted NI Availto Com Stockholders
-46.90
-24.59%
-37.64
-6.53%
-35.33
-148.15%
-14.24
Depreciation Amortization Depletion Income Statement
1.11
-19.64%
1.38
+11.93%
1.23
-4.07%
1.28
Depreciation And Amortization In Income Statement
1.11
-19.64%
1.38
+11.93%
1.23
-4.07%
1.28
Earnings From Equity Interest
-0.05
+75.12%
-0.19
-284.77%
0.10
+130.24%
-0.33
Gain On Sale Of PPE
-0.08
-1094.10%
0.01
+421.61%
-0.00
+98.13%
-0.14
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
24.74
-61.07%
63.56
-33.32%
95.32
-22.56%
123.09
Current Assets
13.69
-57.59%
32.29
-48.03%
62.14
-32.99%
92.73
Cash Cash Equivalents And Short Term Investments
11.88
-60.05%
29.75
-49.19%
58.55
-27.95%
81.26
Cash And Cash Equivalents
11.88
+304.71%
2.94
-80.31%
14.92
-35.07%
22.97
Cash Equivalents
—
0.00
-100.00%
10.60
+4.54%
10.14
Cash Financial
11.88
+304.71%
2.94
-31.98%
4.32
-66.36%
12.83
Other Short Term Investments
0.00
-100.00%
26.81
-38.55%
43.63
-25.15%
58.29
Receivables
0.23
+77.22%
0.13
-59.93%
0.33
-93.87%
5.40
Accounts Receivable
0.19
+43.60%
0.13
-56.38%
0.30
-91.20%
3.45
Gross Accounts Receivable
0.23
-4.89%
0.24
-51.89%
0.50
-92.30%
6.55
Allowance For Doubtful Accounts Receivable
-0.04
+63.31%
-0.11
+45.07%
-0.20
+93.53%
-3.10
Taxes Receivable
0.04
0.00
-100.00%
0.03
-98.56%
1.87
Inventory
0.99
-7.49%
1.07
-35.56%
1.66
-68.65%
5.31
Raw Materials
0.48
-4.99%
0.51
-47.58%
0.96
-75.79%
3.98
Finished Goods
0.51
-9.71%
0.57
-19.01%
0.70
-47.22%
1.33
Prepaid Assets
—
—
—
—
Other Current Assets
0.58
-56.56%
1.34
-16.18%
1.60
+109.82%
0.76
Total Non Current Assets
11.05
-64.67%
31.27
-5.75%
33.18
+9.31%
30.35
Net PPE
3.48
-28.64%
4.88
-18.76%
6.00
+106.16%
2.91
Gross PPE
7.39
-9.42%
8.16
-0.95%
8.23
+92.23%
4.28
Accumulated Depreciation
-3.91
-19.16%
-3.28
-46.96%
-2.23
-62.69%
-1.37
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
0.17
+0.00%
0.17
+0.00%
0.17
+55.00%
0.11
Other Properties
6.25
-11.22%
7.04
-6.35%
7.51
+90.35%
3.95
Leases
0.97
+2.21%
0.95
+72.73%
0.55
+143.89%
0.22
Goodwill And Other Intangible Assets
7.22
-72.34%
26.10
-1.15%
26.40
-1.36%
26.77
Goodwill
—
—
—
0.00
Other Intangible Assets
7.22
-72.34%
26.10
-1.15%
26.40
-1.36%
26.77
Investments And Advances
0.35
+19.12%
0.29
-61.95%
0.77
+14.97%
0.67
Long Term Equity Investment
0.35
+19.12%
0.29
-61.95%
0.77
+14.97%
0.67
Non Current Deferred Assets
—
—
—
—
Non Current Deferred Taxes Assets
—
—
—
—
Total Liabilities Net Minority Interest
4.11
-57.54%
9.69
+4.09%
9.31
+8.65%
8.57
Current Liabilities
3.54
-51.62%
7.32
+27.28%
5.75
+48.38%
3.87
Payables And Accrued Expenses
2.74
-53.15%
5.86
+60.23%
3.66
+93.72%
1.89
Payables
1.88
-42.98%
3.29
+122.27%
1.48
+55.64%
0.95
Accounts Payable
1.88
-42.98%
3.29
+122.27%
1.48
+55.64%
0.95
Current Accrued Expenses
0.87
-66.23%
2.56
+17.91%
2.17
+132.54%
0.93
Total Tax Payable
—
—
—
0.00
Income Tax Payable
—
—
—
0.00
Current Debt And Capital Lease Obligation
0.66
-27.67%
0.92
+9.21%
0.84
+182.09%
0.30
Current Capital Lease Obligation
0.66
-27.67%
0.92
+9.21%
0.84
+182.09%
0.30
Current Deferred Liabilities
0.01
-63.78%
0.04
-88.73%
0.36
0.00
Current Deferred Revenue
0.01
-63.78%
0.04
-88.73%
0.36
0.00
Other Current Liabilities
0.12
-76.33%
0.50
-43.61%
0.89
-47.22%
1.69
Total Non Current Liabilities Net Minority Interest
0.57
-75.79%
2.37
-33.35%
3.56
-24.15%
4.69
Long Term Debt And Capital Lease Obligation
0.57
-53.56%
1.24
-42.54%
2.15
+4144.26%
0.05
Long Term Capital Lease Obligation
0.57
-53.56%
1.24
-42.54%
2.15
+4144.26%
0.05
Tradeand Other Payables Non Current
0.00
-100.00%
0.71
+8.26%
0.66
-44.20%
1.18
Non Current Deferred Liabilities
—
—
0.00
-100.00%
2.42
Non Current Deferred Taxes Liabilities
—
—
0.00
-100.00%
2.42
Other Non Current Liabilities
—
0.42
-43.58%
0.75
-28.27%
1.04
Stockholders Equity
20.63
-61.71%
53.88
-37.36%
86.01
-24.89%
114.52
Common Stock Equity
20.63
-61.71%
53.88
-37.36%
86.01
-24.89%
114.52
Capital Stock
0.07
+78.62%
0.04
+4.97%
0.04
+3.90%
0.03
Common Stock
0.07
+78.62%
0.04
+4.97%
0.04
+3.90%
0.03
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
2.26
+78.62%
1.26
+4.97%
1.20
+3.90%
1.16
Ordinary Shares Number
2.10
+90.15%
1.10
+5.74%
1.04
+1.25%
1.03
Treasury Shares Number
0.16
+0.00%
0.16
+0.00%
0.16
+24.91%
0.13
Additional Paid In Capital
116.51
+13.70%
102.47
+5.85%
96.81
+9.42%
88.47
Retained Earnings
-80.37
-140.08%
-33.48
-828.06%
4.60
-88.48%
39.93
Gains Losses Not Affecting Retained Earnings
0.00
-100.00%
0.42
+185.24%
0.15
-49.96%
0.29
Treasury Stock
15.58
+0.00%
15.58
+0.00%
15.58
+9.60%
14.21
Other Equity Adjustments
—
0.42
+185.24%
0.15
-49.96%
0.29
Total Equity Gross Minority Interest
20.63
-61.71%
53.88
-37.36%
86.01
-24.89%
114.52
Total Capitalization
20.63
-61.71%
53.88
-37.36%
86.01
-24.89%
114.52
Working Capital
10.15
-59.35%
24.98
-55.71%
56.39
-36.54%
88.86
Invested Capital
20.63
-61.71%
53.88
-37.36%
86.01
-24.89%
114.52
Total Debt
1.24
-42.54%
2.15
-28.03%
2.99
+759.56%
0.35
Capital Lease Obligations
1.24
-42.54%
2.15
-28.03%
2.99
+759.56%
0.35
Net Tangible Assets
13.41
-51.72%
27.77
-53.41%
59.61
-32.07%
87.75
Tangible Book Value
13.41
-51.72%
27.77
-53.41%
59.61
-32.07%
87.75
Investmentsin Joint Venturesat Cost
0.35
+19.12%
0.29
-61.95%
0.77
+14.97%
0.67
Non Current Accrued Expenses
—
—
—
—
Non Current Note Receivables
—
—
—
0.00
Notes Receivable
—
—
0.00
-100.00%
0.07
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-29.14
+0.06%
-29.16
-32.03%
-22.08
-436.17%
6.57
Cash Flow From Continuing Operating Activities
-29.14
+0.06%
-29.16
-32.03%
-22.08
-436.17%
6.57
Net Income From Continuing Operations
-46.90
-24.59%
-37.64
-6.53%
-35.33
-148.15%
-14.24
Depreciation Amortization Depletion
1.11
-19.64%
1.38
+11.93%
1.23
-4.07%
1.28
Depreciation And Amortization
1.11
-19.64%
1.38
+11.93%
1.23
-4.07%
1.28
Other Non Cash Items
-0.68
+3.18%
-0.70
+79.74%
-3.46
+72.69%
-12.68
Stock Based Compensation
2.25
-58.64%
5.43
-34.81%
8.34
+10.52%
7.54
Provisionand Write Offof Assets
-0.03
-72.97%
-0.02
-102.45%
0.61
-75.10%
2.46
Asset Impairment Charge
18.83
+5667.34%
0.33
-89.90%
3.23
-79.19%
15.54
Deferred Tax
—
0.00
+100.00%
-2.42
+49.73%
-4.81
Deferred Income Tax
—
0.00
+100.00%
-2.42
+49.73%
-4.81
Operating Gains Losses
-0.55
+19.96%
-0.69
+70.40%
-2.34
-596.98%
0.47
Gain Loss On Investment Securities
-0.68
+21.52%
-0.87
+61.18%
-2.24
—
Change In Working Capital
-3.17
-214.98%
2.75
-51.17%
5.64
-8.89%
6.19
Change In Receivables
-0.03
-117.06%
0.19
-92.65%
2.54
-83.00%
14.92
Changes In Account Receivables
-0.03
-117.06%
0.19
-92.65%
2.54
-83.00%
14.92
Change In Inventory
0.13
-50.56%
0.27
-35.74%
0.41
+111.25%
-3.67
Change In Prepaid Assets
0.59
+42.20%
0.41
-61.94%
1.08
+583.07%
-0.22
Change In Payables And Accrued Expense
-3.83
-272.97%
2.21
+77.52%
1.25
+126.60%
-4.69
Change In Payable
-3.83
-272.97%
2.21
+77.52%
1.25
+126.60%
-4.69
Change In Account Payable
-3.11
-244.26%
2.16
+22.03%
1.77
+171.19%
-2.48
Change In Other Working Capital
-0.03
+91.90%
-0.32
-188.73%
0.36
+341.63%
-0.15
Investing Cash Flow
26.27
+53.91%
17.07
+10.93%
15.39
+126.46%
-58.17
Cash Flow From Continuing Investing Activities
26.27
+53.91%
17.07
+10.93%
15.39
+126.46%
-58.17
Net PPE Purchase And Sale
-0.70
+6.45%
-0.75
+45.19%
-1.37
+4.36%
-1.43
Purchase Of PPE
-0.70
+6.45%
-0.75
+45.19%
-1.37
+4.36%
-1.43
Capital Expenditure
-0.70
+6.45%
-0.75
+45.19%
-1.37
+4.36%
-1.43
Net Investment Purchase And Sale
27.08
+50.73%
17.96
+7.21%
16.75
+129.53%
-56.74
Purchase Of Investment
-6.59
+83.85%
-40.80
+63.07%
-110.50
-62.51%
-68.00
Sale Of Investment
33.67
-42.71%
58.77
-53.82%
127.25
+1030.60%
11.26
Net Business Purchase And Sale
-0.10
+28.65%
-0.14
0.00
0.00
Purchase Of Business
-0.10
+28.65%
-0.14
0.00
—
Financing Cash Flow
11.81
+11266.69%
0.10
+107.62%
-1.36
+90.28%
-14.03
Cash Flow From Continuing Financing Activities
11.81
+11266.69%
0.10
+107.62%
-1.36
+90.28%
-14.03
Net Common Stock Issuance
11.80
+11254.66%
0.10
+107.62%
-1.36
+90.40%
-14.21
Common Stock Payments
—
0.00
+100.00%
-1.36
+90.40%
-14.21
Repurchase Of Capital Stock
—
0.00
+100.00%
-1.36
+90.40%
-14.21
Proceeds From Stock Option Exercised
0.01
0.00
0.00
-100.00%
0.18
Changes In Cash
8.95
+174.69%
-11.98
-48.70%
-8.06
+87.72%
-65.63
Beginning Cash Position
2.94
-80.31%
14.92
-35.07%
22.97
-74.07%
88.61
End Cash Position
11.88
+304.71%
2.94
-80.31%
14.92
-35.07%
22.97
Free Cash Flow
-29.84
+0.22%
-29.90
-27.54%
-23.45
-556.06%
5.14
Interest Paid Supplemental Data
—
—
0.00
0.00
Income Tax Paid Supplemental Data
0.86
0.00
-100.00%
0.06
-98.76%
4.50
Change In Income Tax Payable
-0.71
-1410.47%
0.05
+110.43%
-0.52
+76.28%
-2.20
Change In Tax Payable
-0.71
-1410.47%
0.05
+110.43%
-0.52
+76.28%
-2.20
Common Stock Issuance
11.80
+11254.66%
0.10
0.00
—
Earnings Losses From Equity Investments
0.05
-75.12%
0.19
+284.77%
-0.10
-130.24%
0.33
Issuance Of Capital Stock
11.80
+11254.66%
0.10
0.00
—
Sale Of Business
—
—
—
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category